A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity

被引:43
作者
Fukami, T [1 ]
Nakajima, M [1 ]
Higashi, E [1 ]
Yamanaka, H [1 ]
McLeod, HL [1 ]
Yokoi, T [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
关键词
cytochrome P450; genetic polymorphism; interindividual variability racial difference; coumarin; 7-hydroxylation; nicotine C-oxidation;
D O I
10.1016/j.bcp.2005.05.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human CYP2A6 is a cytochrome P450 (CYP) isoform responsible for the metabolism of nicotine, coumarin, tegafur, and valproic acid, and metabolic activation of nitrosamines. Genetic polymorphisms of the CYP2A6 gene are a major causal factor of the large interindividual differences in nicotine metabolism. In the present study, we identified a novel allele, termed CYP2A6*20, in an African-American population. The allele possesses the deletion of two nucleotides in exon 4 resulting in a frame-shift from codon 196 and an early stop codon at 220 (exon 5) as well as three synonymous SNPs of G51A (G51A in cDNA), T5684C (T1191C), and C6692G (C1546G, 3'-untranslated region). The allele frequency in the African-American population (n = 96) was 1.6% (95% confidence interval, 0.6-4.5%). In contrast, the CYP2A6*20 allele was not found in Caucasians (European-American) (n = 185), Japanese (n = 184) and Korean (n = 209) populations. To investigate the effects of the polymorphism on the enzymatic activities, we expressed a wild type or variant (deletion of two nucleotides) CYP2A6 together with NADPH-CYP reductase in Escherichia coli. SDS-PAGE and immunoblot analyses demonstrated that truncated CYP2A6 protein was produced from the variant allele, although detected mRNA was the predicted size by reverse transcriptional-polymerase chain reaction. Coumarin 7-hydroxylation and nicotine C-oxidation, which are typical CYP2A6 activities, were completely abolished in the E. coli membrane expressing the variant allele. In vivo nicotine metabolism was evaluated using the cotinine/nicotine ratio 2 h after the chewing of one piece of nicotine gum. Two CYP2A6*1/CYP2A6*20 heterozygotes and a single CYP2A6*17/CYP2A6*20 heterozygote revealed lower cotinine/nicotine ratios compared with CYP2A6*1/CYP2A6*1 subjects (1.6 and 4.5, and 1.8 versus 9.5 +/- 5.4, n = 52, respectively). We found a novel CYP2A6*20 allele in African-American subjects which codes a truncated protein lacking enzymatic activity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 20 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafur [J].
Daigo, S ;
Takahashi, Y ;
Fujieda, M ;
Ariyoshi, N ;
Yamazaki, H ;
Koizumi, W ;
Tanabe, S ;
Saigenji, K ;
Nagayama, S ;
Ikeda, K ;
Nishioka, Y ;
Kamataki, T .
PHARMACOGENETICS, 2002, 12 (04) :299-306
[3]   A novel polymorphism of human CYP2A6 gene CTP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo [J].
Fukami, T ;
Nakajima, M ;
Yoshida, R ;
Tsuchiya, Y ;
Fujiki, Y ;
Katoh, M ;
McLeod, HL ;
Yokoi, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (06) :519-527
[4]  
FUKAMI T, IN PRESS DRUG METAB
[5]   Nicotine metabolism and CYP2A6 allele frequencies in Koreans [J].
Kwon, JT ;
Nakajima, M ;
Chai, S ;
Yom, YK ;
Kim, HK ;
Yamazaki, H ;
Sohn, DR ;
Yamamoto, T ;
Kuroiwa, Y ;
Yokoi, T .
PHARMACOGENETICS, 2001, 11 (04) :317-323
[6]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[7]   Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans [J].
Nakajima, M ;
Yamagishi, S ;
Yamamoto, H ;
Yamamoto, T ;
Kuroiwa, Y ;
Yokoi, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (01) :57-69
[8]   Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography [J].
Nakajima, M ;
Yamamoto, T ;
Kuroiwa, Y ;
Yokoi, T .
JOURNAL OF CHROMATOGRAPHY B, 2000, 742 (01) :211-215
[9]   Novel human CYP2A6 alleles confound gene deletion analysis [J].
Nakajima, M ;
Yoshida, R ;
Fukami, T ;
McLeod, HL ;
Yokoi, T .
FEBS LETTERS, 2004, 569 (1-3) :75-81
[10]   Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6 [J].
Nakajima, M ;
Kuroiwa, Y ;
Yokoi, T .
DRUG METABOLISM REVIEWS, 2002, 34 (04) :865-+